Cantel Medical Reports Results For The Third Quarter Ended April 30, 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Piper Jaffray Raises Price Target on Cantel Medical (CMN) Following 3Q15
June 10, 2015 8:21 AM EDTPiper Jaffray reiterates an Overweight rating on Cantel Medical (NYSE: CMN), and raised the price target to $60.00 (from $49.00), following 3Q15. CMN reported sales of $141.5M, which was $5.5M above forecast. Earnings were $0.35, 2 cents above estimates.
Analyst Thomas Gunderson commented, "Strong sales growth of 18% was led by the Endoscopy (up 35%) and Water Purification... More
Cantel Medical (CMN) Tops Q3 EPS by 6c
June 9, 2015 8:08 AM EDTCantel Medical (NYSE: CMN) reported Q3 EPS of $0.35, $0.06 better than the analyst estimate of $0.29. Revenue for the quarter came in at $120.06 million versus the consensus estimate of $135.95 million.
For earnings history and earnings-related data on Cantel Medical (CMN) click here.
... More